June’s HSI and MSCI China Index rose 3.4% mom and 4.0% mom respectively, despite the pullback due to the Middle East tensions. July may see increased volatility as the US looks to bring the tariff negotiations to a close. At this juncture, we continue to favour domestic policy beneficiaries and sector leaders. New additions to our BUY list are CATL, KE Holdings, Longfor, Midea Group, Tencent and Tencent Music Entertainment. We take profit on Prudential.
GREATER CHINA Strategy Alpha Picks: July Conviction Calls Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. Sector Online Games Upcoming new game releases to capitalise on the summer holiday season. INDONESIA Strategy Alpha Picks: Good Performances In June Our new alpha picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA...
During the Hangzhou humanoid robot show, there was notable enthusiasm from the supply chain on the opportunities arising from humanoid robots, with an abundance of participants specialising in harmonic reducers, miniaturised screws bearings, while the dexterous hands and ball screw suppliers are the points of interest. Nevertheless, there is a general consensus that the current technology is still immature, and a resolution to the roadblocks will come more gradually in the next few years. Mainta...
We continue to see rapid developments in China’s humanoid robot space, with supply chain players and key developers turning increasingly optimistic about the industry’s outlook. Comments indicate that technology development will take 2-3 years before full replacement of workers is feasible. Nevertheless, shipments will ramp up rapidly in the coming years, with cost reduction likely exceeding previous expectations. Maintain MARKET WEIGHT.
The HSI and MSCI China index rebounded 5.3% mom and 3.5% mom respectively in May, after China and the US agreed on a 90-day tariff truce. Nonetheless, geopolitical uncertainties and tariff war risks remain. Hence, we continue to favour domestic policy beneficiaries and defensive sectors that have been gaining traction in recent weeks. New additions to our BUY list are Prudential and Sino Biopharm, and we take profit on SHKP and Trip.com.
GREATER CHINA Strategy Alpha Picks: June Conviction Calls Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and TCOM. Update Qingdao Port International (6198 HK/NOT RATED/Price: HK$6.54) Key takeaways from NDR. INDONESIA Update Sumber Alfaria Trijaya (AMRT IJ/BUY/Rp2,620/Target: Rp3,000) Synergy potential from Lawson; expansion outside Java remains intact. MALAYSIA Strategy 1Q25 Results Wrap-Up ...
The HSI and MSCI China index fell 4.3% mom and 5.2% mom respectively in April, driven by Trump’s tariff announcements in early-April and fears of a potential global recession. Due to the ongoing external uncertainties, we will maintain our exposure to domestic policy beneficiaries and defensive sectors. New additions to our BUY list are Alibaba, Innovent, Shuanghuan, and Trip.com, and we take profit of CR Land and JBM Healthcare.
GREATER CHINA Strategy Alpha Picks: May Conviction Calls Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. Sector Aviation Airlines: 1Q25 results below expectations. Weak fuel prices to support full-year performance. Maintain UNDERWEIGHT. INDONESIA Strategy 1Q25 Results Recap ...
HL’s 4Q24/1Q25 net profit was below our/market expectations, primarily due to a worse-than-expected gross margin. Throughout 1Q25, we saw signs of a sustained recovery in capex, likely partially driven by front-loading of demand prior to the announcement of US tariffs. However, due to the worse-than-expected tariffs, we believe the company is now subjected to similar downside risks like other Chinese domestic manufacturers. Maintain BUY; trim target price to Rmb32.20.
KEY HIGHLIGHTS Sector Property In Apr 25, major mainland cities saw mom/yoy decreases in new home sales, while second-hand transactions in Tier 1 cities continued to see positive yoy growth. The supportive remarks by Premier Li Qiang on 15 April point to further upside on property policies. The upcoming Politburo meeting will be an important window for clues of new policies. Maintain OVERWEIGHT. CR Land remains our top pick. Results Fuyao Glass Industry Group (3606 HK/BUY/HK$49.15/Target: ...
GREATER CHINA Sector Property Supportive policy remarks by Premier Li Qiang point to further upside; upcoming Politburo meeting to be an important policy window. Results Fuyao Glass Industry Group (3606 HK/BUY/HK$49.15/Target: HK$68.00) 1Q25: Earnings up 46% yoy, in line with estimates. Maintain BUY. Target price: HK$68.00. Han’s Laser (002008 CH/BUY/Rmb24.27/Target: Rmb32.20) 1Q25: Net pro...
The IT hardware sector registered corrections in share price in the past two weeks as market realised that contribution from the exciting GenAI-driven applications are unlikely to be meaningful in 2025. Nevertheless, the potential cost savings and efficiency boost facilitated by AI are clear and we expect investments into applications development to remain high. Maintain OVERWEIGHT and expect downstream AI applications to remain a key investment focus through 2025.
The HSI and MSCI China index rose 0.8% mom and 2.0% mom respectively in March, after the DeepSeek fervour passed and investors locked in profits ahead of Trump’s tariff announcement in early-April. In the face of geopolitical uncertainties and potential trade war escalations, we will keep our exposure to companies reliant on domestic demand and beneficiaries of policy support. New additions to our BUY list are CR Beer, Desay SV, JBM Healthcare, JD Logistics, Minth, WuXi App Tech and Xiaomi Corp.
The HSI and MSCI China index rose 13.4% mom and 11.5% mom respectively in February, riding the wave of optimism on China’s tech sector. Sino-US tensions look set to rise in March, as higher tariffs take effect and should lead to greater market volatility. Hence, we will be quick to take profit and will only add names with less demanding valuations. New additions to our BUY list are Geely, JD, SHKP and Zijin Mining.
The HSI and MSCI China index rose 0.8% mom and 0.9% mom respectively in January as investors awaited clarity on Sino-US relations and any additional Chinese stimulus. Looking ahead, we will focus on oversold names, policy beneficiaries and stocks that will also be quick to book profits due to greater market volatility. We are adding AIA, CR land, Haier and Han’s Laser to our BUY list. We take profits on Crystal, Geely, Trip.com and Weimob, and cut losses on Sinopharm.
Expect increased market volatility in 1H25 as the US embarks on another round of trade rebalancing with China via higher tariffs. We expect China to roll out growth supportive policies on top of the de-risking measures that have been announced. Hence, we prefer a domestic orientation and policy beneficiaries for 1H25. Our MSCI China Index target is at 68pt, based on 7% EPS growth and 10.5x PE. The downside target is 51pt in the event of a full-fledged trade war. China is focusing on de-riskin...
Han’s Laser’s 3Q24 net profit declined 4.2% yoy to Rmb200m, which is below consensus estimate, likely due to higher-than-expected opex. PCB and general laser equipment remained the key growth drivers; the panel equipment business started to recover as well. However, we expect a better recovery in 2025, as we see improving visibility of a sustainable recovery in 2025 from electronics-related businesses. Downgrade to HOLD due to fair valuation and trim target price to Rmb22.70.
KEY HIGHLIGHTS Results Hong Kong Exchanges and Clearing (388 HK/BUY/HK$314.80/Target: HK$364.00) HKEX reported a 6.5% yoy earnings growth in 3Q24 after a sharp increase in headline ADT following the rollout of stimulus packages by China in late-September. Although market velocity has normalised, ADT remains elevated, and NII could be more resilient going forward, suggesting more upside for earnings. The risk-to-reward ratio is more balanced now after the recent correction as HKEX is trading ...
GREATER CHINA Results Hong Kong Exchanges and Clearing (388 HK/BUY/HK$314.80/Target: HK$364.00) 3Q24: Risk-and-reward is more balanced. Upgrade to BUY. Han’s Laser (002008 CH/HOLD/Rmb24.42/Target: Rmb22.70) 3Q24: Net profit misses, but visibility of recovery improving. Downgrade to HOLD. New Oriental Education & Technology Group (EDU US/BUY/US$62.15/Target: US$85.00) 1QFY25: In line; moderated growth outlook in 2QFY25 on low seasonality. Update Xtep International Holdings (...
Han’s Laser’s 2Q24 core net profit declined 6% yoy to Rmb226m, at the mid-point of the guided range. Revenue and margins were largely in line, with the recovery in PCB and IT business offset by the sluggish renewables and automotive related businesses. Going forward, the worst is likely over and we expect the PCB business’ momentum to pick up in 2H24, driven by the recovery in 3C, and the strong growth in AI-related demand. Upgrade to BUY, raise target price to Rmb23.30.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.